TriSalus Life Sciences, Inc.
TLSI- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001826667
No open-market purchases or sales by TriSalus Life Sciences, Inc. insiders were filed in the last 90 days; 78 institutions reported holding it in 13F filings for Q2 2026, worth $99.0M in total; no superinvestor holds it.
Other share classesTLSIW
13F holders, Q1 2025
Institutional positions in TriSalus Life Sciences, Inc. as of Mar 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 34
- +6 vs. Q4 2024
- Shares held
- 2.95M
- +602.1K (+25.7%) vs. Q4 2024
- Total value
- $16.3M
- +$4.52M (+38.5%) vs. Q4 2024
- New holders
- 12
- 11 more added
- Sold out
- 6
- 1 more reduced
Compare with Q4 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TLSI on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 78 | $99.0M |
| Q1 2026 | 84 | $83.4M |
| Q4 2025 | 64 | $79.6M |
| Q3 2025 | 56 | $44.5M |
| Q2 2025 | 46 | $46.2M |
| Q1 2025 | 34 | $16.3M |
| Q4 2024 | 28 | $11.8M |
| Q3 2024 | 31 | $10.0M |
| Q2 2024 | 27 | $9.20M |
| Q1 2024 | 25 | $9.03M |
| Q4 2023 | 19 | $5.74M |
| Q3 2023 | 9 | $699.3K |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2025
Shares, value and share of portfolio for each institution holding TriSalus Life Sciences, Inc.; share changes are against Q4 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Gilder Gagnon Howe & Co LLC | 827,357 | $4.57M | 0.06% | +812,937+5,637.6% | Added |
| Wealthcare Advisory Partners LLC | 643,740 | $3.55M | 0.10% | 00.0% | Unchanged |
| Vanguard Group Inc | 486,618 | $2.69M | 0.00% | +10,326+2.2% | Added |
| Geode Capital Management, LLC | 219,424 | $1.21M | 0.00% | +15,287+7.5% | Added |
| Bank of America Corp | 185,532 | $1.02M | 0.00% | +7,086+4.0% | Added |
| Millennium Management LLC | 133,380 | $736.3K | 0.00% | +52,842+65.6% | Added |
| Bridgeway Capital Management, LLC | 65,000 | $358.8K | 0.01% | 00.0% | Unchanged |
| MSD Partners, L.P. | 39,999 | $220.8K | 0.16% | 00.0% | Unchanged |
| Northern Trust Corp | 39,926 | $220.4K | 0.00% | +7,814+24.3% | Added |
| Goldman Sachs Group Inc | 33,900 | $187.1K | 0.00% | +33,900 | New |
| BlackRock, Inc. | 30,270 | $167.1K | 0.00% | 00.0% | Unchanged |
| Connective Capital Management, LLC | 29,079 | $160.5K | 0.15% | +1,090+3.9% | Added |
| Citadel Advisors LLC | 26,580 | $146.7K | 0.00% | +26,580 | New |
| Vestcor Inc | 23,376 | $129.0K | 0.00% | 00.0% | Unchanged |
| Connecticut Wealth Management, LLC | 22,303 | $123.1K | 0.01% | 00.0% | Unchanged |
| State Street Corp | 20,200 | $111.5K | 0.00% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 20,200 | $111.5K | 0.00% | +6,800+50.7% | Added |
| Cambridge Investment Research Advisors, Inc. | 15,554 | $86.0K | 0.00% | 00.0% | Unchanged |
| Lido Advisors, LLC | 14,197 | $78.4K | 0.00% | +173+1.2% | Added |
| HRT Financial LP | 13,657 | $75.0K | 0.00% | +13,657 | New |
| Balyasny Asset Management LLC | 10,804 | $59.6K | 0.00% | +10,804 | New |
| Two Sigma Securities, LLC | 10,596 | $58.5K | 0.01% | +10,596 | New |
| Charles Schwab Investment Management Inc | 10,000 | $55.2K | 0.00% | +10,000 | New |
| Prudential Financial Inc | 10,000 | $55.2K | 0.00% | +10,000 | New |
| UBS Group AG | 6,809 | $37.6K | 0.00% | +6,787+30,850.0% | Added |
| SRS Capital Advisors, Inc. | 4,008 | $22.1K | 0.00% | +4,008 | New |
| Morgan Stanley | 2,361 | $13.0K | 0.00% | +2,361 | New |
| Wells Fargo & Company | 1,001 | $5.53K | 0.00% | +1,000+100,000.0% | Added |
| Citigroup Inc | 958 | $5.29K | 0.00% | +958 | New |
| Hoertkorn Richard Charles | 668 | $3.69K | 0.00% | 00.0% | Unchanged |
| Coldstream Capital Management Inc | 150 | $828 | 0.00% | +150 | New |
| Signaturefd, LLC | 100 | $552 | 0.00% | 00.0% | Unchanged |
| Barclays PLC | 32 | $177 | 0.00% | +32 | New |
| JPMorgan Chase & Co | 21 | $116 | 0.00% | −3−12.5% | Reduced |
| Duquesne Family Office LLCSuperinvestorDuquesne Family Office | 0 | $0 | 0.00% | −426,921−100.0% | Sold out |
| Angelo Gordon & Co., L.P. | 0 | $0 | 0.00% | −10,854−100.0% | Sold out |
| Exos Asset Management LLC | 0 | $0 | 0.00% | −3,604−100.0% | Sold out |
| Wolverine Asset Management LLC | 0 | $0 | 0.00% | −1,032−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −555−100.0% | Sold out |
| Advisor Group Holdings, Inc. | 0 | $0 | 0.00% | −79−100.0% | Sold out |